Skip to content

Prospective, non-interventional clinical study of preeclampsia test kit for predicting preeclampsia/eclampsia /HELLP in pregnant women with suspected preeclampsia

Prospective, non-interventional clinical study of preeclampsia test kit for predicting preeclampsia/eclampsia /HELLP in pregnant women with suspected preeclampsia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074878
Enrollment
Unknown
Registered
2023-08-18
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia

Interventions

Gold Standard:The gold standard for clinical diagnosis of preeclampsia is: new hypertension (systolic blood pressure =140mmHg and/or diastolic blood pressure =90mmHg) after 20 weeks of pregnancy with
? Renal impairment (serum creatinine >1.1 mg/dL or > 97.2µmol/L)
? Pulmonary edema
(5) New abnormalities of the central nervous system or visual disturbances.
Index test:Urine misfolded protein and Congo red binding test, the test dish colored red defined positive, colorless defined negative.

Sponsors

Department of Obstetrics and Gynecology, Women's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 years old 2. Gestational age 20+0 to 33+6 3. Single pregnancy 4. Clinically suspected preeclampsia meets one or more of the following criteria: (1) New hypertension (systolic =130 mmHg and/or diastolic =80 mmHg); (2) Increased blood pressure (non-hypertensive patients increased more than 30/15 mmHg from the basic blood pressure, hypertensive patients showed a significant increase trend or beyond controlled based on the original treatment); (3) New proteinuria (no urinary tract infection and urinary protein =1+); (4) One or more clinical symptoms showed suspected preeclampsia (other possible causes have been ruled out).

Exclusion criteria

Exclusion criteria: (1) Diagnosed preeclampsia/chronic hypertension with preeclampsia (2) Diagnosed eclampsia (3) Diagnosed HELLP syndrome (4) Fetal chromosomal abnormalities (5) Participating in another drug clinical study (6) Received investigational intervention drugs within 3 months (7) Hematuria (8) History of nephropathy

Design outcomes

Primary

MeasureTime frame
Detection rate of preeclampsia;Accuracy;Sensitivity;Specificity;Positive predicative value;

Countries

China

Contacts

Public ContactBai Xiaoxia

Department of Obstetrics and Gynecology, Women's Hospital, Zhejiang University School of Medicine

baixiaoxia@zju.edu.cn+86 571 8999 3062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 9, 2026